A previous study found that recombinant human IL-35 reduced the serum levels of TC and TG, but not affected the LDL-C and HDL-C levels in ApoE-/- mice [25], indicating that the effect of IL-35 on lowering lipids is associated with the reduction of atherosclerosis. The gene discussed is APOE; the disease is atherosclerosis.